FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Progesterone Injection, USP
Status: Currently in Shortage
»Date first posted: 12/21/2017
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Fresenius Kabi USA, LLC (Revised 10/15/2018)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg per 10 mL, MDV (NDC 63323-0261-10) Backordered. Next release December 2018. Manufacturing delay

Teva Pharmaceuticals (Reverified 10/11/2018)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50MG 1X10ML (NDC 0591-3128-79) Teva has inventory, but product will continue to be allocated until demand and inventory replenishment stabilize. Demand increase for the drug

West-Ward Pharmaceuticals (Reverified 10/03/2018)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mg/mL, 10 mL (NDC 0143-9725-01) Available Additional lots are scheduled to be manufactured. Product will be made available as it is released. Information pending

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English